Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Cash from Operations (2016 - 2025)

Organogenesis Holdings (ORGO) has 10 years of Cash from Operations data on record, last reported at 39420000.0 in Q4 2025.

  • For Q4 2025, Cash from Operations rose 260.43% year-over-year to 39420000.0; the TTM value through Dec 2025 reached 10309000.0, down 172.56%, while the annual FY2025 figure was 10309000.0, 172.56% down from the prior year.
  • Cash from Operations reached 39420000.0 in Q4 2025 per ORGO's latest filing, up from 3079000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 39420000.0 in Q4 2025 and bottomed at 32873000.0 in Q2 2025.
  • Average Cash from Operations over 5 years is 6082650.0, with a median of 8223000.0 recorded in 2022.
  • Peak YoY movement for Cash from Operations: skyrocketed 287.25% in 2021, then plummeted 793.82% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 17948000.0 in 2021, then tumbled by 56.54% to 7800000.0 in 2022, then skyrocketed by 36.08% to 10614000.0 in 2023, then rose by 3.04% to 10937000.0 in 2024, then surged by 260.43% to 39420000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 39420000.0 in Q4 2025, 3079000.0 in Q3 2025, and 32873000.0 in Q2 2025.